Log in
f

New drug to protect babies and toddlers from RSV gets FDA approval ahead of cold season

By MATTHEW PERRONE
Posted 7/17/23

U.S. officials have approved a new long-acting drug to protect babies and toddlers against a respiratory virus that causes thousands of hospitalizations each year. The Food and Drug Administration on …

This item is available in full to subscribers.

Please log in to continue

Log in